Eli Lilly and Co. is pushing hard to gain a sales edge against two other drugmakers in the war against metastatic breast cancer. It is spending hundreds of millions of dollars to win over patients ...
Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to endocrine therapy alone In the seven-year ...
While the Summer Olympics don't start until later this month, Eli Lilly and its Team USA athletes are already taking on health conditions in ads and videos for Lilly medicines. Lilly-sponsored Olympic ...
Last October, England’s drug-cost watchdogs dealt Eli Lilly a blow when they decreed that the company’s CDK 4/6 inhibitor to treat breast cancer, Verzenio, wasn't cost-effective. So Lilly dished up a ...
TORONTO, Aug. 8, 2019 /CNW/ - Eli Lilly Canada Inc. (Lilly Canada) is pleased to announce the availability of VERZENIO™ (abemaciclib). VERZENIO is indicated for the treatment of estrogen and/or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback